Desloratadine/pseudoephedrine

Desloratadine/pseudoephedrine, sold under the brand name Clarinex-D among others, is a medication used for the treatment of seasonal allergic rhinitis.^[1][2]

Desloratadine/pseudoephedrine

Combination of
Desloratadine	Antihistamine
Pseudoephedrine	Decongestant
Clinical data
Trade names	Clarinex-D, Aerinaze
AHFS/Drugs.com	Micromedex Detailed Consumer Information
License data	US DailyMed: Clarinex-D
Routes of administration	By mouth
ATC code	R01BA52 (WHO)
Legal status
Legal status	US: ℞-only[1] EU: Rx-only[2] In general: ℞ (Prescription only)
Identifiers
CAS Number	2447632-94-0
KEGG	D10850

Desloratadine/pseudoephedrine was approved for use in the United States in 2005^[1][3] and in the European Union in July 2007.^[2]

Medical uses

Desloratadine/pseudoephedrine is indicated for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.^[2]